Source: 4-traders

Immunarray: Quanterix and ImmunArray Teaming Up to Address Neurodegenerative Disease

(4-traders.com) Quanterix gains access to ImmunArray brain injury biomarker portfolio and ImmunArray gains access to Quanterix state of the art digital biomarker technology ...http://www.4-traders.com/news/Quanterix-and-ImmunArray-Teaming-Up-to-Address-Neurodegenerative-Disease--23127934/

Read full article »

Immunarray's Competitors | Immunarray's News | Immunarray's Financials

Followers on Owler

176

Est. Annual Revenue

$5.0-25M

Est. Employees

1-25

CEO

Susan Evans

CEO Approval Rating

85/100

immunArray is a molecular diagnostics company that is engaged in developing novel blood-based tests to support the diagnosis and management of autoimmune diseases.